Pay in 4 interest-free payments of $7.23 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Surg Obes Relat Dis 21:689694 Abi Mosleh K, Salameh Y, Ghusn W et al (2024) Impact of metabolic and bariatric surgery on weight loss and insulin requirements in type 1 and insulin-treated type 2 diabetes
Real-world data from endocrinology practices shows that patients on both medications experience less predictable glucose control, with wider daily fluctuations than those on either drug alone
The FDA approved Wegovy in 2021 for weight loss in adults in patients with a body mass index (BMI) of 30 or greater or with a BMI of 27 or greater and at least one weight-related condition like high blood pressure or high cholesterol
PubMed: Panda PK et al
Many reported benefits come from small trials, mechanistic studies, or real-world clinical experience, including our own patient feedback here at MedClub
The participants' average duration of use was 8.3 months, with an average weight loss of 11.3 kg
US$ 21.23
US$ 28.64
US$ 23.10
US$ 27.56
US$ 23.79
